NeoTract | 合法醫療器材資訊網

The UroLift System is indicated for the treatment of symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH) in men age 50 ... Read More

2020年12月2日 — The UroLift System is intended for the treatment of symptoms due to urinary ... Table 11-6 Effect of the Modified UroLift System on FDA Identified ... Read More

2020年6月5日 — Trade/Device Name: UroLift Advanced Tissue Control (ATC) System ... at https://​www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm ... Read More

The UroLift System is an FDA Cleared, revolutionary minimally invasive treatment of Benign Prostatic Hyperplasia (BPH) or an enlarged prostate. Read More

2020年1月7日 — The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic ... Read More

Your doctor will use the UroLift Delivery Device to deploy permanent implants to relieve obstruction caused by the enlarged prostate that is pressing on your ... Read More

UroLift System Treatment Delivers a Superior Patient Experience: · Rapid relief and recovery · Lowest catheter rate of the leading BPH procedures · No new, ... Read More

The UroLift System uses a revolutionary approach to treating BPH that lifts and holds the enlarged prostate tissue out of the way so it no longer blocks the ... Read More

2020年1月7日 — Teleflex's UroLift wins new FDA designation ... Teleflex (NYSE:TFX) said today that the FDA has granted the company an expanded indication for ... Read More

NeoTract, Inc. Receives U.S. FDA De Novo Approval for the UroLift® Prostate Implant. Breakthrough Technology Approved for Treatment of BPH Delivers ... Read More